Regeneron Study Site

Oklahoma City, Oklahoma

We've found

2 trials

at this facility

Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Patients With Platinum-Resistant Ovarian Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Oklahoma City, OK

Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Oklahoma City, OK

Use our guide to learn which trials are right for you!